Handelen CVS Health - CVS CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.15 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.030779% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.013666% | ||||||||
| Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
CVS Health Corp ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 85.7 |
| Open* | 85.75 |
| 1-Jaarlijkse Verandering* | -21.44% |
| Dagelijks bereik* | 85.24 - 85.86 |
| 52 wekelijks bereik | 84.82-111.25 |
| Weekgemiddelde volume (10 dagen) | 10.72M |
| Gemiddeld volume (3 maanden) | 147.03M |
| Marktkapitalisatie | 112.70B |
| P/E Ratio | 36.45 |
| Uitstaande Aandelen | 1.31B |
| Omzet | 315.23B |
| EPS | 2.35 |
| Dividend (opbrengst %) | 1.01082 |
| Beta | 0.62 |
| Volgende inkomsten datum | Feb 8, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 85.70 | -0.79 | -0.91% | 86.49 | 87.52 | 85.52 |
| Feb 2, 2023 | 86.07 | -0.02 | -0.02% | 86.09 | 86.91 | 85.35 |
| Feb 1, 2023 | 87.36 | -0.55 | -0.63% | 87.91 | 88.10 | 86.53 |
| Jan 31, 2023 | 88.09 | 1.24 | 1.43% | 86.85 | 88.41 | 86.85 |
| Jan 30, 2023 | 86.98 | -0.82 | -0.93% | 87.80 | 88.29 | 86.91 |
| Jan 27, 2023 | 87.68 | 0.03 | 0.03% | 87.65 | 88.04 | 86.92 |
| Jan 26, 2023 | 87.55 | 1.18 | 1.37% | 86.37 | 87.69 | 85.95 |
| Jan 25, 2023 | 85.68 | 0.63 | 0.74% | 85.05 | 85.94 | 84.75 |
| Jan 24, 2023 | 85.95 | -0.47 | -0.54% | 86.42 | 86.91 | 85.84 |
| Jan 23, 2023 | 87.13 | 0.28 | 0.32% | 86.85 | 87.38 | 86.51 |
| Jan 20, 2023 | 86.93 | -0.41 | -0.47% | 87.34 | 87.41 | 86.69 |
| Jan 19, 2023 | 87.40 | 0.27 | 0.31% | 87.13 | 88.22 | 86.94 |
| Jan 18, 2023 | 88.09 | -1.36 | -1.52% | 89.45 | 89.64 | 87.96 |
| Jan 17, 2023 | 89.26 | -0.74 | -0.82% | 90.00 | 90.43 | 89.03 |
| Jan 13, 2023 | 89.83 | 1.20 | 1.35% | 88.63 | 90.33 | 88.45 |
| Jan 12, 2023 | 89.11 | -0.55 | -0.61% | 89.66 | 89.90 | 88.94 |
| Jan 11, 2023 | 89.71 | -1.87 | -2.04% | 91.58 | 91.58 | 89.29 |
| Jan 10, 2023 | 90.56 | 0.31 | 0.34% | 90.25 | 91.29 | 88.40 |
| Jan 9, 2023 | 91.44 | -0.65 | -0.71% | 92.09 | 93.18 | 91.33 |
| Jan 6, 2023 | 91.53 | 0.55 | 0.60% | 90.98 | 91.86 | 90.81 |
CVS Health Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totale inkomsten | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
| Inkomsten | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
| Kosten van opbrengsten, totaal | 146533 | 153448 | 156447 | 158719 | 163981 | 175803 |
| Brutowinst | 31013 | 31338 | 38132 | 98057 | 104725 | 116308 |
| Totale bedrijfskosten | 167803 | 175248 | 190558 | 244868 | 256235 | 279370 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 18448 | 18809 | 21368 | 396 | 461 | 523 |
| Ongebruikelijke uitgaven (inkomsten) | 643 | 181 | 6149 | 559 | 1503 | 2373 |
| Other Operating Expenses, Total | 2179 | 2810 | 6594 | 85194 | 90290 | 100671 |
| Bedrijfsresultaat | 9743 | 9538 | 4021 | 11908 | 12471 | 12741 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -1078 | -1062 | -2619 | -3035 | -2907 | -2503 |
| Overige, Netto | -28 | -208 | 4 | 124 | 206 | 182 |
| Netto inkomen voor belastingen | 8637 | 8268 | 1406 | 8997 | 9770 | 10420 |
| Netto inkomen na belastingen | 5320 | 5131 | -696 | 6631 | 7201 | 7898 |
| Minderheidsbelang | -2 | -1 | 2 | 3 | -13 | 12 |
| Netto inkomen voor extra. Posten | 5318 | 5130 | -694 | 6634 | 7188 | 7910 |
| Totale buitengewone posten | -1 | 1492 | 100 | 0 | -9 | 0 |
| Netto inkomen | 5317 | 6622 | -594 | 6634 | 7179 | 7910 |
| Total Adjustments to Net Income | -26 | -16 | -3 | 0 | 0 | |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 5292 | 5114 | -697 | 6634 | 7188 | 7910 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
| Verwaterd Netto Inkomen | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
| Verwaterd Gewogen Gemiddelde Aandelen | 1079 | 1024 | 1044 | 1305 | 1314 | 1329 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 4.90454 | 4.99414 | -0.66762 | 5.08352 | 5.47032 | 5.95184 |
| Dividends per Share - Common Stock Primary Issue | 1.7 | 2 | 2 | 2 | 2 | 2 |
| Verwaterde Genormaliseerde Winst per Aandeel | 5.2716 | 5.10383 | 3.16078 | 5.51501 | 6.31339 | 7.27044 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 69097 | 72616 | 73794 | 76604 | 76826 |
| Inkomsten | 69097 | 72616 | 73794 | 76604 | 76826 |
| Kosten van opbrengsten, totaal | 40894 | 43520 | 45011 | 46378 | 45509 |
| Brutowinst | 28203 | 29096 | 28783 | 30226 | 31317 |
| Totale bedrijfskosten | 65520 | 68290 | 71096 | 74464 | 73336 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 8881 | 8829 | 9190 | ||
| Ongebruikelijke uitgaven (inkomsten) | 41 | 40 | 814 | 1478 | 525 |
| Other Operating Expenses, Total | 15704 | 15901 | 16081 | 26608 | 27302 |
| Bedrijfsresultaat | 3577 | 4326 | 2698 | 2140 | 3490 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -657 | -636 | -602 | -608 | -586 |
| Overige, Netto | 50 | 45 | 49 | 38 | 42 |
| Netto inkomen voor belastingen | 2970 | 3735 | 2145 | 1570 | 2946 |
| Netto inkomen na belastingen | 2224 | 2791 | 1587 | 1296 | 2313 |
| Minderheidsbelang | -1 | -8 | 11 | 10 | -1 |
| Netto inkomen voor extra. Posten | 2223 | 2783 | 1598 | 1306 | 2312 |
| Netto inkomen | 2223 | 2783 | 1598 | 1306 | 2312 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 2223 | 2783 | 1598 | 1306 | 2312 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 2223 | 2783 | 1598 | 1306 | 2312 |
| Verwaterd Netto Inkomen | 2223 | 2783 | 1598 | 1306 | 2312 |
| Verwaterd Gewogen Gemiddelde Aandelen | 1322 | 1327 | 1329 | 1338 | 1328 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.68154 | 2.09721 | 1.20241 | 0.97608 | 1.74096 |
| Dividends per Share - Common Stock Primary Issue | 0.5 | 0.5 | 0.5 | 0.5 | 0.55 |
| Verwaterde Genormaliseerde Winst per Aandeel | 1.70477 | 2.08539 | 1.65557 | 1.88793 | 2.05135 |
| Totale buitengewone posten | 0 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totaal vlottende activa | 31042 | 31229 | 45243 | 50302 | 56369 | 60008 |
| Geldmiddelen en kortetermijnbeleggingen | 3458 | 1807 | 6581 | 8056 | 10854 | 12525 |
| Geldmiddelen & Equivalenten | 3371 | 1696 | 4059 | 5683 | 7854 | 9408 |
| Korte Termijn Investeringen | 87 | 111 | 2522 | 2373 | 3000 | 3117 |
| Totale Vorderingen, Netto | 12164 | 13181 | 17631 | 19617 | 21742 | 24431 |
| Accounts Receivable - Trade, Net | 12164 | 13181 | 17631 | 17236 | 7101 | 7932 |
| Total Inventory | 14760 | 15296 | 16450 | 17516 | 18496 | 17760 |
| Other Current Assets, Total | 660 | 945 | 4581 | 5113 | 5277 | 5292 |
| Total Assets | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
| Property/Plant/Equipment, Total - Net | 10175 | 10292 | 11349 | 32904 | 33335 | 32018 |
| Property/Plant/Equipment, Total - Gross | 22802 | 24290 | 26869 | 49794 | 52035 | 52672 |
| Accumulated Depreciation, Total | -12627 | -13998 | -15520 | -16890 | -18700 | -20654 |
| Goodwill, Net | 38249 | 38451 | 78678 | 79749 | 79552 | 79121 |
| Intangibles, Net | 13511 | 13630 | 36524 | 33121 | 31142 | 29026 |
| Other Long Term Assets, Total | 1485 | 1529 | 8930 | 9059 | 9505 | 9801 |
| Total Current Liabilities | 26250 | 30648 | 44009 | 53303 | 62017 | 67807 |
| Accounts Payable | 17397 | 19218 | 26437 | 30972 | 34869 | 38682 |
| Accrued Expenses | 6937 | 6609 | 10711 | 13656 | 15810 | 19229 |
| Notes Payable/Short Term Debt | 1874 | 1276 | 720 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 42 | 3545 | 1265 | 3781 | 5440 | 4205 |
| Total Liabilities | 57632 | 57440 | 138231 | 158585 | 161326 | 157924 |
| Total Long Term Debt | 25615 | 22181 | 71444 | 64699 | 59207 | 51971 |
| Long Term Debt | 25615 | 22181 | 71444 | 63918 | 58157 | 50721 |
| Deferred Income Tax | 4214 | 2996 | 7677 | 7294 | 6794 | 6270 |
| Minority Interest | 4 | 4 | 318 | 306 | 312 | 306 |
| Other Liabilities, Total | 1549 | 1611 | 14783 | 32983 | 32996 | 31570 |
| Total Equity | 36830 | 37691 | 58225 | 63864 | 69389 | 75075 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 17 | 17 | 45440 | 45972 | 46513 | 47377 |
| Additional Paid-In Capital | 31618 | 32079 | ||||
| Retained Earnings (Accumulated Deficit) | 38983 | 43556 | 40911 | 45108 | 49640 | 54906 |
| Treasury Stock - Common | -33483 | -37796 | -28228 | -28235 | -28178 | -28173 |
| Other Equity, Total | -305 | -165 | 5 | 245 | 200 | 187 |
| Total Liabilities & Shareholders’ Equity | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
| Total Common Shares Outstanding | 1061 | 1014 | 1295 | 1302 | 1310 | 1322 |
| Long Term Investments | 15732 | 17314 | 20812 | 23025 | ||
| Other Current Liabilities, Total | 4876 | 4894 | 5898 | 5691 | ||
| Unrealized Gain (Loss) | 97 | 774 | 1214 | 778 | ||
| Capital Lease Obligations | 781 | 1050 | 1250 | |||
| Total Preferred Shares Outstanding | 0 | 0 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 55719 | 56559 | 60842 | 60008 | 61483 |
| Geldmiddelen en kortetermijnbeleggingen | 8788 | 10125 | 12841 | 12525 | 11342 |
| Geldmiddelen & Equivalenten | 5598 | 7119 | 9826 | 9408 | 8442 |
| Korte Termijn Investeringen | 3190 | 3006 | 3015 | 3117 | 2900 |
| Totale Vorderingen, Netto | 23855 | 24164 | 25283 | 24431 | 26451 |
| Accounts Receivable - Trade, Net | 18304 | 18976 | 8398 | 7932 | 8728 |
| Total Inventory | 17618 | 16979 | 17399 | 17760 | 18160 |
| Other Current Assets, Total | 5458 | 5291 | 5319 | 5292 | 5530 |
| Total Assets | 229606 | 231164 | 234891 | 232999 | 232873 |
| Property/Plant/Equipment, Total - Net | 33153 | 33140 | 33233 | 32018 | 31645 |
| Goodwill, Net | 79552 | 79552 | 79121 | 79121 | 79060 |
| Intangibles, Net | 30639 | 30080 | 29545 | 29026 | 28543 |
| Long Term Investments | 21025 | 22136 | 22370 | 23025 | 22595 |
| Other Long Term Assets, Total | 9518 | 9697 | 9780 | 9801 | 9547 |
| Total Current Liabilities | 60104 | 59311 | 64709 | 67807 | 69780 |
| Accounts Payable | 35358 | 36691 | 39468 | 38682 | 41570 |
| Accrued Expenses | 16018 | 16539 | 17871 | 19229 | 18388 |
| Notes Payable/Short Term Debt | 252 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2422 | 60 | 1561 | 4205 | 4217 |
| Other Current Liabilities, Total | 6054 | 6021 | 5809 | 5691 | 5605 |
| Total Liabilities | 158756 | 157920 | 160583 | 157924 | 159043 |
| Total Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
| Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
| Deferred Income Tax | 6610 | 6557 | 6329 | 6270 | 5829 |
| Minority Interest | 314 | 321 | 310 | 306 | 310 |
| Other Liabilities, Total | 32458 | 32437 | 32403 | 31570 | 31061 |
| Total Equity | 70850 | 73244 | 74308 | 75075 | 73830 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 46727 | 46995 | 47133 | 47377 | 47677 |
| Retained Earnings (Accumulated Deficit) | 51203 | 53331 | 54264 | 54906 | 56488 |
| Treasury Stock - Common | -28102 | -28252 | -28166 | -28173 | -30145 |
| Unrealized Gain (Loss) | 828 | 977 | 904 | 778 | -377 |
| Other Equity, Total | 194 | 193 | 173 | 187 | 187 |
| Total Liabilities & Shareholders’ Equity | 229606 | 231164 | 234891 | 232999 | 232873 |
| Total Common Shares Outstanding | 1313 | 1318 | 1321 | 1322 | 1306 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Geldmiddelen uit Operationele Activiteiten | 10141 | 8007 | 8865 | 12848 | 15865 | 18265 |
| Cash Receipts | 172310 | 176594 | 186519 | 248393 | 264327 | 284219 |
| Cash Payments | -142511 | -146469 | -148821 | -149655 | -158636 | -165783 |
| Cash Taxes Paid | -3060 | -2909 | -2383 | -2717 | -2929 | -3195 |
| Contant Betaalde Rente | -1140 | -1072 | -2803 | -2954 | -2904 | -2469 |
| Veranderingen in het Operationeel Kapitaal | -15458 | -18137 | -23647 | -80219 | -83993 | -94507 |
| Geldmiddelen uit Investeringsactiviteiten | -2470 | -2877 | -43285 | -3339 | -5534 | -5261 |
| Kapitaaluitgaven | -2224 | -1918 | -2037 | -2457 | -2437 | -2520 |
| Overige Cash Flow investeringsposten, Totaal | -246 | -959 | -41248 | -882 | -3097 | -2741 |
| Geldmiddelen uit Financieringsactiviteiten | -6761 | -6751 | 36819 | -7654 | -7696 | -11356 |
| Financiering van Cash Flow Posten | -142 | -72 | 350 | 59 | 337 | -13 |
| Total Cash Dividends Paid | -1840 | -2049 | -2038 | -2603 | -2624 | -2625 |
| Uitgifte (Aflossing) van aandelen, netto | -4165 | -4032 | 242 | 210 | 264 | 549 |
| Uitgifte (Aflossing) van Schulden, Netto | -614 | -598 | 38265 | -5320 | -5673 | -9267 |
| Wisselkoerseffecten | 2 | 1 | -4 | |||
| Nettowijziging in Geldmiddelen | 912 | -1620 | 2395 | 1855 | 2635 | 1648 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Cash From Operating Activities | 2892 | 8739 | 14260 | 18265 | 3563 |
| Cash Receipts | 66487 | 136621 | 209104 | 284219 | 74192 |
| Cash Payments | -39171 | -79316 | -122129 | -165783 | -44365 |
| Cash Taxes Paid | -44 | -1552 | -2397 | -3195 | -96 |
| Cash Interest Paid | -876 | -1263 | -2095 | -2469 | -782 |
| Changes in Working Capital | -23504 | -45751 | -68223 | -94507 | -25386 |
| Cash From Investing Activities | -1867 | -2974 | -3821 | -5261 | -1993 |
| Capital Expenditures | -829 | -1315 | -1923 | -2520 | -1082 |
| Other Investing Cash Flow Items, Total | -1038 | -1659 | -1898 | -2741 | -911 |
| Cash From Financing Activities | -3185 | -6558 | -8525 | -11356 | -2650 |
| Financing Cash Flow Items | 56 | -159 | -164 | -13 | -211 |
| Total Cash Dividends Paid | -656 | -1306 | -1965 | -2625 | -722 |
| Issuance (Retirement) of Stock, Net | 212 | 330 | 440 | 549 | -1703 |
| Issuance (Retirement) of Debt, Net | -2797 | -5423 | -6836 | -9267 | -14 |
| Net Change in Cash | -2160 | -793 | 1914 | 1648 | -1080 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7762 | 115316851 | 1721829 | 2022-09-30 | LOW |
| Capital World Investors | Investment Advisor | 4.6346 | 60896763 | 2060715 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.586 | 60258711 | 234645 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.4403 | 58344728 | -339582 | 2022-09-30 | LOW |
| Capital International Investors | Investment Advisor | 1.9717 | 25907490 | -351533 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7789 | 23374421 | 186288 | 2022-09-30 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 1.6592 | 21801147 | 696280 | 2022-09-30 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.5392 | 20224681 | 368634 | 2022-09-30 | LOW |
| BofA Global Research (US) | Research Firm | 1.1617 | 15264714 | 80812 | 2022-09-30 | LOW |
| Dodge & Cox | Investment Advisor/Hedge Fund | 1.0254 | 13472772 | -236945 | 2022-09-30 | LOW |
| Invesco Advisers, Inc. | Investment Advisor | 0.9993 | 13129851 | -500609 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9936 | 13055500 | -67996 | 2021-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.9056 | 11899729 | 224538 | 2022-09-30 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7675 | 10085134 | -130262 | 2022-09-30 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7495 | 9847659 | -473501 | 2022-09-30 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.726 | 9539067 | -771778 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.7187 | 9443400 | -8279 | 2022-09-30 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6884 | 9045542 | -197163 | 2022-09-30 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.673 | 8843195 | -63183 | 2022-09-30 | LOW |
| Nordea Funds Oy | Investment Advisor | 0.6619 | 8697324 | -983166 | 2022-09-30 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group +485000+
Handelaren
65000+
Actieve klanten per maand
$48000000+
Maandelijks beleggingsvolume
$28000000+
Probeer het nu Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Handelscommissie
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Hefboom
20:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
CVS Company profile
Over CVS Health
CVS Health Corporation is, samen met haar dochterondernemingen, een onderneming die gezondheidsoplossingen aanbiedt. De segmenten van de onderneming zijn Farmaceutische diensten, Kleinhandel/LTC, Gezondheidszorg voordelen en Bedrijf/Ander. Het segment Farmaceutische Diensten biedt een reeks oplossingen aan voor het beheer van apothekersvoordelen (PBM), waaronder het ontwerp en de administratie van plannen, diensten voor het beheer van apotheeknetwerken, postorderapotheken, gespecialiseerde apotheken, klinische diensten, diensten voor ziektebeheer en beheer van medische uitgaven. Het Retail/LTC segment verkoopt geneesmiddelen op recept en een reeks gezondheids- en welzijnsproducten en algemene koopwaar. Het segment Health Care Benefits biedt een scala aan traditionele, vrijwillige en consumentgerichte zorgverzekeringsproducten en aanverwante diensten. De diensten van de Onderneming omvatten gezondheids- en welzijnsdiensten, gezondheidsplannen, apotheekdiensten en dekking van geneesmiddelen op recept. De onderneming heeft ongeveer 9.900 detailhandelsvestigingen, meer dan 1.200 medische inloopziekenhuizen, een apothekersvoordeelbeheerder.
| Industry: | Healthcare Facilities & Services (NEC) |
1 Cvs Dr
WOONSOCKET
RHODE ISLAND 02895-6146
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 485.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen